Both in R&D — Physical & Biological Sciences
IB Acquisition vs NRC Health
Over the past year IBAC returned +3.7% and NRC returned +69.2%; their daily moves had a correlation of -0.05.
IBAC +3.7% NRC +69.2%Growth of $1, one year, split-adjusted
| Metric | IBAC | NRC |
|---|---|---|
| Price | $10.81 | $26.34 |
| Market cap | $54.1M | $559.0M |
| Today | −0.46% | −2.70% |
| 1 month | −0.6% | +30.5% |
| 6 months | −0.2% | +40.6% |
| Year to date | +3.0% | +40.3% |
| 1 year | — | +91.1% |
| Revenue growth (YoY) | — | +11.0% |
| Gross margin | — | 60.0% |
| Net margin | — | 12.3% |
| P/E (TTM) | — | 91.1× |
| Price / sales | — | 3.9× |
| Net cash | — | -$99.3M |
| Dividend yield | — | 2.43% |
| Volatility (60d) | 20.1% | 49.9% |
| Short % of float | 0.3% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).